Showing 5731-5740 of 5956 results for "".
- Prevent Blindness Elects Three New Members to National Board of Directorshttps://modernod.com/news/prevent-blindness-elects-three-new-members-to-national-board-of-directors-2/2479700/Prevent Blindness has announced that Paul Delatore, Global Head, Market Access at Alcon; Jim McGrann, Chairman & CEO of Healthy Eyes Advantage; and Rajeev S. Ramchandran, MD, Associate Professor of Ophthalmology in the University of Rochester Medical School’s Department of Ophthalmology, have
- Ophthalmologists Implant First Visian Toric ICLs in the UShttps://modernod.com/news/ophthalmologists-implant-first-visian-toric-icls-in-the-us/2479710/Staar Surgical announced the first patient implants of the company’s Visian Toric Implantable Collamer Lenses (TICLs) in the United States by Brinton Vision in St. Louis and Parkhurst NuVision in San Antonio. A select group of lea
- Horizon Pharma Announces Presentation of Results of 48 Week Off-Therapy Follow-Up to the Phase 2 Trial of Teprotumumab at AAOhttps://modernod.com/news/horizon-pharma-announces-presentation-of-results-of-48-week-off-therapy-follow-up-to-the-phase-2-trial-of-teprotumumab-at-aao/2479711/Horizon Pharma announced that more detailed results from the 48 week off-therapy follow-up to the phase 2 clinical trial of teprotumumab for people living with moderate-to-severe active thyroid eye disease (TED) were presented at the AAO annual meeting, Oct. 27–30, 2018, in Chicago. The data was
- Ophthotech Expands Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4https://modernod.com/news/ophthotech-expands-retinal-disease-pipeline-with-acquisition-of-versant-ventures-inception-4/2479712/Ophthotech Corporation announced that it has acquired Inception 4, a privately held company backed by Versant Ventures, expanding Ophthotech’s therapeutic pipeline in age-related retinal indications. Through this acquisition, Ophthotech gains worldwide development and commercialization rig
- Aura Biosciences Reports Positive Phase 1b/2 Clinical Data for AU-011https://modernod.com/news/aura-biosciences-reports-positive-phase-1b-2-clinical-data-for-au-011/2479713/Aura Biosciences has reported positive clinical data from its phase 1b/2 clinical trial evaluating the safety and efficacy of light-activated AU-011, its lead product candidate for the primary treatment of choroidal melanoma. “Ocular melanoma is the most
- The Retina Group of Washington Will Merge With Maryland’s Retina Associateshttps://modernod.com/news/the-retina-group-of-washington-will-merge-with-marylands-retina-associates/2479714/The Retina Group of Washington (RGW), a leading provider of retinal and macular care in the Washington, D.C., metropolitan area, has announced plans to merge with Retina Associates (RA), a 5-office practice operating in suburban Maryland locations, according to a
- Nicox Postpones Nasdaq Listing Due to Market Volatilityhttps://modernod.com/news/nicox-postpones-nasdaq-listing-due-to-market-volatility/2479717/Nicox SA announced that due to the extreme volatility of the financial markets, it has decided to postpone its dual listing on Nasdaq, concluding that it would not be in the interest of their existing shareholders at this time, according to a company news release. The purpose of a Nasdaq l
- Report: Laser Vision Correction Procedure Volume Increases for Third Straight Yearhttps://modernod.com/news/report-laser-vision-correction-procedure-volume-increases-for-third-straight-year/2479719/Laser vision correction procedure volume in the United States increased for the third year in a row, indicating a growing demand for LASIK and other laser vision correction procedures, according to data released by the Refractive Surgery Council (RSC). Year-to-date laser vision correction
- Study: Diabetes Medication May Protect Against AMDhttps://modernod.com/news/study-diabetes-medication-may-protect-against-amd/2479722/Researchers from Taiwan have shown that people with type 2 diabetes who took a common diabetes medication, metformin, had a significantly lower rate of age-related macular degeneration (AMD). The study suggests that the anti-inflammatory and anti-oxidative effects
- Spectralis High Magnification Module Receives FDA Clearancehttps://modernod.com/news/spectralis-high-magnification-module-receives-fda-clearance/2479726/Heidelberg Engineering announced it has received FDA clearance for its Spectralis High Magnification Module. This new module consists of a highly innovative lens and software upgrade that will be available for new and